Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Village Compounding Pharmacy
WARNING LETTER
•Village Compounding Pharmacy

Village Compounding Pharmacy – FDA Warning Letter

Record Details

The FDA issued a Warning Letter to Village Compounding Pharmacy after reviewing their website, www.villagecompounding.com, identifying several violations related to their compounded hormone therapy drugs.

The firm's compounded hormone therapy drugs are deemed misbranded under Section 502(a) of the FDCA due to false and misleading claims. The website presented unsubstantiated efficacy claims for "BIO-IDENTICAL HRT" in treating conditions like fibrocystic breasts, depression, and heart disease, and for "ESTROGENS" improving memory, sleep, and mood. Additionally, unsubstantiated superiority claims suggested their compounded drugs were better than synthetic or animal hormones, and unsubstantiated "bio-identical" claims implied their products were natural or identical to body-produced hormones. The FDA stated it is unaware of substantial evidence (adequate and well-controlled clinical investigations) to support these claims.

Furthermore, the firm is compounding hormone therapy drugs containing estriol, which are considered unapproved new drugs under Section 505 of the FDCA. Estriol is not a component of an FDA-approved drug, and the firm lacks an FDA-sanctioned investigational new drug application. These estriol-containing drugs are also misbranded under Section 502(f)(1) of the FDCA because their labeling fails to bear adequate directions for use and they are not exempt from this requirement.

The FDA requires the firm to take prompt action to correct these

Company
Village Compounding Pharmacy
Product type
Drugs
Office
Dallas District Office
Person
  • Elaine R. Crosby
View Company Profile

ID · 3a68b369-3c59-4725-9c39-a5c279f565db

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 352(a)21 U.S.C. 35521 U.S.C. 352(f)(1)21 U.S.C. 321(n)21 U.S.C. 321(p)21.U.S.C. 355(a)21 U.S.C. 355(i)FD&C Act 502(a)FD&C Act 505

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Village Compounding Pharmacy
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.